Iraqi Kurds seek independence through shady oil sales
One of Boeing's dreariest performers continues to be its highest-tech, most fuel-efficient airplane
Here's what some veteran Kremlin-watchers have to say
A rougher-than-expected quarterly loss gives Amazon bulls something to think about and may enable Amazon executives to press for slower expansion
After a lull, lenders scramble to keep up with demand
Ministry of Supply’s Aviator jacket combines the structure of a tailored garment with the functionality of a windbreaker
Some well-funded startups are betting the Internet can help reinvent shopping's least pleasant experience: the bra fitting
The Boston Celtics power forward, who filed for bankruptcy in 2010, says athletes need more business education
Millions of workers at American small businesses aren’t guaranteed any time off after the birth of a child
San Mateo, Calif.
Founders: Dr. Michael Selley, Dr. Lawrence Steinman, and Dr. Marc Feldmann
VC Investment over the last four quarters: $27 million
Founded in Australia in 2005 and established in the U.S. in 2007, Nuon Therapeutics is a clinical stage company developing oral treatments for multiple sclerosis and rheumatoid arthritis. The six-employee firm, which had previously raised a $5 million Series A round, is continuing development while conserving cash during the downturn, says CEO Rodney Pearlman. "Since we are in clinical stage development, this can be an expensive phase, so we have to ensure we meet our goals while being fiscally responsive to the current environment," he says.
Key to startup success: "Be opportunistic and think outside the box."